Optimising Clinical Success With Foundational Heart Failure Treatment

  • Published:  05 December 2022
  • Likes: 

    Heart Icon

    3

Up Next

Optimising Clinical Success With Foundational Heart Failure Treatment

  • Published:  05 December 2022
  • Likes: 

    Heart Icon

    3

Average (ratings)
No ratings
Your rating
Overview

This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice. 

 

In this first discussion, Prof Andrew Coats (Heart Research Institute, Sydney, AU) and Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, Kansas City, US) address how to optimise clinical success using foundational heart failure treatment. 

 

Split into three short videos, Prof Coats and Dr Kosiborod start by summarising current foundational heart failure therapy and how guidance has recently changed across the spectrum of ejection fraction. Following this, they explore recent evidence supporting initiation of GDMT and offer practical advice for the implementation of treatment, including possible solutions to the early uptake of GDMT.

 

The full series of videos entitled 'Incorporating GDMT and PRO Endpoints for Personalised Heart Failure Management' is available to watch, or you can take the course to earn 1 CME credit. 

 

This programme is supported by an unrestricted educational grant from AstraZeneca.

Key Learning Objectives

  • Review current GDMT in HFrEF and HFpEF
  • Describe the relationship between initiation of GDMT and HF outcomes
  • Prescribe GDMT according to current international recommendations

Target Audience

  • Cardiologists
  • Heart Failure Specialists
  • Primary Care Physicians
  • Nurses
  • Pharmacists
  • Other allied HCPs

More from this programme

Part 1

What is GDMT?

In this opening video, Prof Coats and Dr Kosiborod summarise foundational GDMT across the spectrum of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

Part 2

Early Initiation and Better Clinical Outcomes

Part 3

Achieving Early Uptake of GDMT

Faculty Biographies